SoundThinking, Inc. (SSTI)
NASDAQ: SSTI · Real-Time Price · USD
12.95
+1.77 (15.83%)
Aug 13, 2025, 4:00 PM - Market closed
Elevation Oncology Stock Forecast
Stock Price Forecast
The 8 analysts that cover Elevation Oncology stock have a consensus rating of "Buy" and an average price target of $20.25, which forecasts a 56.37% increase in the stock price over the next year. The lowest target is $16 and the highest is $30.
Price Target: $20.25 (+56.37%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Elevation Oncology stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Hold | 2 | 2 | 2 | 2 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 9 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Strong Buy Maintains $20 → $19 | Strong Buy | Maintains | $20 → $19 | +46.72% | Aug 13, 2025 |
| Roth MKM | Roth MKM | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +131.66% | May 14, 2025 |
| Lake Street | Lake Street | Strong Buy Maintains $18 → $20 | Strong Buy | Maintains | $18 → $20 | +54.44% | May 14, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $20 | Buy | Reiterates | $20 | +54.44% | May 14, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Buy Reiterates $19 | Buy | Reiterates | $19 | +46.72% | Mar 17, 2025 |
Financial Forecast
Revenue This Year
113.46M
from 102.03M
Increased by 11.20%
Revenue Next Year
123.40M
from 113.46M
Increased by 8.76%
EPS This Year
-0.23
from -0.72
EPS Next Year
-0.09
from -0.23
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 117.6M | 131.2M |
| Avg | 113.5M | 123.4M |
| Low | 108.3M | 112.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | 15.2% | 15.6% |
| Avg | 11.2% | 8.8% |
| Low | 6.1% | -0.8% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | -0.05 | 0.18 |
| Avg | -0.23 | -0.09 |
| Low | -0.40 | -0.30 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.